216 related articles for article (PubMed ID: 38176772)
41. A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine.
Reddy S; Reddy S; Arora M
Cureus; 2021 May; 13(5):e14837. PubMed ID: 33968543
[TBL] [Abstract][Full Text] [Related]
42. Monitoring of cerebral oximetry in patients with postural orthostatic tachycardia syndrome.
Kharraziha I; Holm H; Bachus E; Melander O; Sutton R; Fedorowski A; Hamrefors V
Europace; 2019 Oct; 21(10):1575-1583. PubMed ID: 31384930
[TBL] [Abstract][Full Text] [Related]
43. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular profile in postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome type III.
Cheng JL; Au JS; Guzman JC; Morillo CA; MacDonald MJ
Clin Auton Res; 2017 Apr; 27(2):113-116. PubMed ID: 28005189
[TBL] [Abstract][Full Text] [Related]
45. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
Hviid A; Thorsen NM; Valentiner-Branth P; Frisch M; Mølbak K
BMJ; 2020 Sep; 370():m2930. PubMed ID: 32878745
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome.
Boris JR; Bernadzikowski T
Auton Neurosci; 2021 Mar; 231():102770. PubMed ID: 33388686
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
Miller AJ; Stiles LE; Sheehan T; Bascom R; Levy HP; Francomano CA; Arnold AC
Auton Neurosci; 2020 Mar; 224():102637. PubMed ID: 31954224
[TBL] [Abstract][Full Text] [Related]
48. Orthostatic intolerance without postural tachycardia: how much dysautonomia?
Parsaik AK; Singer W; Allison TG; Sletten DM; Joyner MJ; Benarroch EE; Low PA; Sandroni P
Clin Auton Res; 2013 Aug; 23(4):181-8. PubMed ID: 23729158
[TBL] [Abstract][Full Text] [Related]
49. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.
Olshansky B; Cannom D; Fedorowski A; Stewart J; Gibbons C; Sutton R; Shen WK; Muldowney J; Chung TH; Feigofsky S; Nayak H; Calkins H; Benditt DG
Prog Cardiovasc Dis; 2020; 63(3):263-270. PubMed ID: 32222376
[TBL] [Abstract][Full Text] [Related]
50. Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome.
Garland EM; Gamboa A; Nwazue VC; Celedonio JE; Paranjape SY; Black BK; Okamoto LE; Shibao CA; Biaggioni I; Robertson D; Diedrich A; Dupont WD; Raj SR
J Am Coll Cardiol; 2021 May; 77(17):2174-2184. PubMed ID: 33926653
[TBL] [Abstract][Full Text] [Related]
51. Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome.
Medic Spahic J; Ricci F; Aung N; Hallengren E; Axelsson J; Hamrefors V; Melander O; Sutton R; Fedorowski A
BMC Cardiovasc Disord; 2020 Apr; 20(1):190. PubMed ID: 32321428
[TBL] [Abstract][Full Text] [Related]
52. Cardiac origins of the postural orthostatic tachycardia syndrome.
Fu Q; Vangundy TB; Galbreath MM; Shibata S; Jain M; Hastings JL; Bhella PS; Levine BD
J Am Coll Cardiol; 2010 Jun; 55(25):2858-68. PubMed ID: 20579544
[TBL] [Abstract][Full Text] [Related]
53. [Postural orthostatic tachycardia syndrome (POTS)--pathophysiology, diagnostics, and treatment].
Rek M; Kaczmarek K; Cygankiewicz I; Wranicz JK; Ptaszyński P
Przegl Lek; 2014; 71(8):450-3. PubMed ID: 25546918
[TBL] [Abstract][Full Text] [Related]
54. A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder.
Celletti C; Borsellino B; Castori M; Censi F; Calcagnini G; Camerota F; Strano S
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32434316
[TBL] [Abstract][Full Text] [Related]
55. Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study.
Jost K; Rodriguez B; Söll N; Hoepner R; Z'Graggen WJ
F1000Res; 2022; 11():215. PubMed ID: 37822957
[No Abstract] [Full Text] [Related]
56. Use of an allostatic neurotechnology by adolescents with postural orthostatic tachycardia syndrome (POTS) is associated with improvements in heart rate variability and changes in temporal lobe electrical activity.
Fortunato JE; Tegeler CL; Gerdes L; Lee SW; Pajewski NM; Franco ME; Cook JF; Shaltout HA; Tegeler CH
Exp Brain Res; 2016 Mar; 234(3):791-8. PubMed ID: 26645307
[TBL] [Abstract][Full Text] [Related]
57. Postural tachycardia in hypermobile Ehlers-Danlos syndrome: A distinct subtype?
Miglis MG; Schultz B; Muppidi S
Auton Neurosci; 2017 Dec; 208():146-149. PubMed ID: 28986003
[TBL] [Abstract][Full Text] [Related]
58. The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.
Stewart JM; Kota A; O'Donnell-Smith MB; Visintainer P; Terilli C; Medow MS
J Appl Physiol (1985); 2020 Sep; 129(3):459-466. PubMed ID: 32702262
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of postural tachycardia syndrome (POTS).
Goodman BP
Auton Neurosci; 2018 Dec; 215():12-19. PubMed ID: 29705015
[TBL] [Abstract][Full Text] [Related]
60. Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome.
Brewster JA; Garland EM; Biaggioni I; Black BK; Ling JF; Shibao CA; Robertson D; Raj SR
Clin Sci (Lond); 2012 Jan; 122(1):25-31. PubMed ID: 21751966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
